| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.50B | 2.42B | 3.59B | 1.52B | 1.19B |
| Gross Profit | 1.41B | 266.10M | 2.17B | 1.52B | 247.50M |
| EBITDA | 323.30M | 156.20M | 2.08B | 119.50M | 118.60M |
| Net Income | 225.50M | 113.30M | 2.13B | 52.60M | 68.30M |
Balance Sheet | |||||
| Total Assets | 9.37B | 11.77B | 10.03B | 8.31B | 7.05B |
| Cash, Cash Equivalents and Short-Term Investments | 1.25B | 1.11B | 1.32B | 3.53B | 2.83B |
| Total Debt | 843.20M | 448.90M | 448.20M | 476.00M | 478.30M |
| Total Liabilities | 6.97B | 9.32B | 7.58B | 6.33B | 5.03B |
| Stockholders Equity | 2.40B | 2.45B | 2.45B | 1.98B | 2.01B |
Cash Flow | |||||
| Free Cash Flow | -409.50M | 613.60M | 488.80M | 722.60M | 338.70M |
| Operating Cash Flow | -408.30M | 618.20M | 495.20M | 741.40M | 345.80M |
| Investing Cash Flow | 682.70M | -475.80M | -834.90M | 215.90M | -1.09B |
| Financing Cash Flow | 19.80M | -153.90M | -106.90M | -16.20M | -18.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | $32.79B | 7.15 | 19.02% | ― | 16.68% | -28.54% | |
79 Outperform | $981.16M | 8.68 | 18.79% | 4.00% | 0.76% | ― | |
70 Outperform | $9.31B | 11.89 | 15.32% | 6.98% | 7.08% | -4.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $39.65B | 15.62 | 7.50% | 2.02% | -23.02% | 52.43% | |
60 Neutral | $1.54B | 66.09 | -30.28% | ― | 24.81% | 55.93% | |
56 Neutral | $1.61B | 9.21 | -0.57% | 2.55% | 11.71% | -101.08% |
On March 2, 2026, Fidelis Insurance Group announced it had entered into a definitive agreement to repurchase all 8,597,170 remaining common shares held by founding shareholder CVC Falcon Holdings Limited for $19.00 per share, totaling about $163.3 million. Executives said buying the stock below the firm’s year-end 2024 diluted book value per share of $24.61 should be meaningfully accretive to book value and return on equity, while also simplifying the shareholder base as CVC exits its ownership stake.
Management framed the deal as a vote of confidence in Fidelis’s balance sheet strength and growth trajectory, highlighting continued momentum and an ongoing commitment to long-term value creation for remaining investors. The transaction underscores Fidelis’s use of capital management, including targeted buybacks, to bolster its market positioning in specialty insurance and reinsurance, with legal advisory support on the deal provided by Sidley Austin LLP.
The most recent analyst rating on (FIHL) stock is a Buy with a $26.50 price target. To see the full list of analyst forecasts on Fidelis Insurance Holdings Ltd. stock, see the FIHL Stock Forecast page.
Fidelis Insurance Holdings reported sharply improved results for the fourth quarter and full year 2025, highlighting a fourth-quarter combined ratio of 80.6% and annualized operating return on average equity of 18.3%. The group also disclosed record gross premiums written of $4.7 billion in 2025, book value growth to $24.61 per diluted share, and total capital returns of $133.6 million to shareholders in the fourth quarter, including sizable buybacks and dividends.
For the quarter ended December 31, 2025, net income reached $117.8 million and operating net income $110.4 million, driven by a swing from prior-year reserve strengthening to $35.4 million of favorable development and lower catastrophe and large losses. For the full year, Fidelis generated $225.5 million of net income and an improved 94.8% combined ratio, while on February 25, 2026 it also announced plans to change its corporate name to Pelagos Insurance Capital Limited, signaling a potential rebranding as it seeks to reinforce its positioning in specialty insurance and reinsurance markets.
The most recent analyst rating on (FIHL) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Fidelis Insurance Holdings Ltd. stock, see the FIHL Stock Forecast page.
On February 20, 2026, Fidelis Insurance Group announced that its board had expanded the company’s common share repurchase authorization to a total of $400 million and declared a quarterly dividend of $0.15 per common share, payable on March 27, 2026, to shareholders of record on March 16, 2026. These moves continue a pattern of capital return that saw $313.7 million distributed in 2025, including sizable buybacks and dividends, and are intended to capitalize on what management views as a significant discount to net book value while signaling confidence in the firm’s capital position and ongoing specialty underwriting strategy.
The company highlighted that it repurchased 15,184,976 common shares for $261.4 million in 2025, including two privately negotiated transactions totaling $75 million with CVC Falcon Holdings Limited in the fourth quarter. Management framed the enlarged buyback capacity and ongoing dividend as giving Fidelis added flexibility to balance growth opportunities with shareholder returns, potentially enhancing earnings per share and reinforcing its value-focused positioning in the specialty insurance and reinsurance market.
The most recent analyst rating on (FIHL) stock is a Sell with a $17.50 price target. To see the full list of analyst forecasts on Fidelis Insurance Holdings Ltd. stock, see the FIHL Stock Forecast page.